Sectors
INO
Inovio Pharmaceuticals, Inc.
1.27
1 x 1.09
1 x 1.46
bid
ask
-
0.02
1.55%
1 @ 04:00 PM
1.27 +0.00 (0.00%)
| Ytd | -27.01% | |
| 1y | -46.41% |
1.26
day range
1.37
0.56
52 week range
2.98
| Open | 1.30 | Prev Close | 1.29 | Low | 1.26 | High | 1.37 | Mkt Cap | 131.31M |
| Vol | 5.62M | Avg Vol | 3.29M | EPS | -1.01 | P/E | N/A | Forward P/E | -0.48 |
| Beta | 0.83 | Short Ratio | 11.22 | Inst. Own | 33.51% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-10 | 50-d Avg | 1.05 | 200-d Avg | 1.45 | 1yr Est | 10.67 |
| Income Statement | |||
| Operating Expenses | 18.62M | ||
| Research and Development Expense | 10.83M | ||
| Selling, General and Administrative Expense | 7.80M | ||
| Operating Income | -18.62M | ||
| Net Income | -6.01M | ||
| Net Income Common Stock | -6.01M | ||
| Net Income Common Stock (USD) | -6.01M | ||
| Consolidated Income | -6.01M | ||
| Earnings per Basic Share | -0.07 | ||
| Earnings per Basic Share (USD) | -0.07 | ||
| Earnings per Diluted Share | -0.07 | ||
| Earning Before Interest & Taxes (EBIT) | -6.01M | ||
| Earning Before Interest & Taxes (USD) | -6.01M | ||
| Weighted Average Shares | 81.62M | ||
| Weighted Average Shares Diluted | 81.62M | ||
| Balance Sheet | |||
| Cash and Equivalents | 31.53M | ||
| Cash and Equivalents (USD) | 31.53M | ||
| Investments | 5.15M | ||
| Investments Current | 5.15M | ||
| Current Assets | 39.91M | ||
| Property, Plant & Equipment Net | 7.56M | ||
| Total Assets | 49.39M | ||
| Debt Current | 2.90M | ||
| Total Debt | 8.00M | ||
| Current Liabilities | 39.92M | ||
| Debt Non-Current | 5.10M | ||
| Total Liabilities | 45.02M | ||
| Accumulated Retained Earnings (Deficit) | -1.84B | ||
| Accumulated Other Comprehensive Income | -279.98K | ||
| Shareholders Equity | 4.37M | ||
| Shareholders Equity (USD) | 4.37M | ||
| Assets Non-Current | 9.48M | ||
| Total Debt (USD) | 8.00M | ||
| Liabilities Non-Current | 5.10M | ||
| Trade and Non-Trade Payables | 11.65M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 765.89K | ||
| Net Cash Flow from Financing | 17.16M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 5.25M | ||
| Issuance (Purchase) of Equity Shares | 3.25M | ||
| Net Cash Flow from Investing | 6.15M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 6.15M | ||
| Net Cash Flow from Operations | -18.05M | ||
| Share Based Compensation | 768.44K | ||